Kanamycin
Back to searchMolecule Structure
Scientific Name
Kanamycin
Description of the Drug
Kanamycin is an aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01172
http://www.drugbank.ca/drugs/DB01172
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Warner Chilcott Div Warner Lambert Co, Apothecon Inc Div Bristol Myers Squibb, Solopak Laboratories Inc, Watson Laboratories Inc, Pharmafair Inc, Loch Pharmaceuticals Inc, Abraxis Pharmaceutical Products, International Medication Systems Ltd, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2735 | |||
PharmGKB | PA450137 | |||
Human Metabolome Database | HMDB0015303 | |||
DrugBank | DB01172 | |||
PubChem: Thomson Pharma | 14785807 | 16090268 | ||
PubChem | 6032 | |||
NMRShiftDB | 60027773 | |||
LINCS | LSM-5261 | |||
Nikkaji | J4.492J | |||
PDBe | KAN | |||
BindingDB | 50031282 | |||
EPA CompTox Dashboard | DTXSID3023184 | |||
DrugCentral | 1519 | |||
Metabolights | MTBLC17630 | |||
Brenda | 229549 | 789 | 5165 | 229550 |
ChemicalBook | CB2402286 | |||
rxnorm | KANAMYCIN A SULFATE | KANAMYCIN | ||
KEGG Ligand | C01822 | |||
ChEBI | 17630 | |||
ZINC | ZINC000008214590 |